Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stress Ulcer Prophylaxis Versus Placebo - a Blinded Randomized Control Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart Disease

NCT03667703 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03667703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stress Ulcer Prophylaxis Versus Placebo - a Blinded Randomized Control Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart Disease
Lead sponsor
Boston Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 10, 2019
Completion date
June 30, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, infection, stress ulcer, upper gastrointestinal bleeding